COL18A1 and corneal ulcer: Suppressed corneal neovascularization accompanied by enhanced corneal healing outcomes was consistently reported in numerous studies which have evaluated the application of endostatin (i.e., in its native protein form, engineered or modified variants, or via gene delivery) in corneal ulcer and corneal injury models [274,275,276,277,278].